Funder: National Institutes of Health (NIH)
Due Dates: October 30, 2025 (anticipated)
Funding Amounts: Estimated total program funding: $12,000,000; ~6 awards expected; UM1 Cooperative Agreement; typical project period and award size not yet specified.
Summary: Supports Lead Academic Organizations in the NCI Experimental Therapeutics Clinical Trials Network to design, conduct, and oversee early phase cancer clinical trials.
Key Information: This is a forecasted opportunity; applications are not yet being accepted.